ACE2 and malaria: Given the selective advantage offered by malaria through a wide distribution of blood group O in Africa, the enormous spread of the angiotensin-converting enzyme II (ACE2) deletion among many African ethnic groups might have reduced COVID-19 susceptibility in Africans (24).